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A Potential Flippase in Trafficking
 
Adding material to one leaflet of the lipid bilayer, at the
expense of the other, can do work and bend the mem-
brane. The findings of Chen et al. (page 1223) are the first
hint that such a mechanism may be used in protein traf-
ficking, in this case in the budding yeast TGN. Doubts re-
main, however, about the ability of Drs2p (the trafficking
protein studied by Chen et al.) to move lipids from one
side of a membrane to the other.
 
Chen et al. identify a 
 
drs2
 
 mutation as being syntheti-
cally lethal with a deletion in ADP-ribosylation factor 1
(ARF1). ARF1 is one of two redundant ARFs. Both re-
cruit two coat proteins: COPI for Golgi to ER transport,
and clathrin, possibly for TGN to endosome transport.
Drs2p appears to function in the clathrin pathway, as a
 
drs2
 
 deletion interacts only with mutations in clathrin and
a protein from clathrin-coated pits, and the deletion strain
accumulates excess Golgi membranes and fewer clathrin-
coated vesicles. Drs2p localizes to the TGN.
Drs2p is most similar to the bovine P-type ATPase II, a
possible aminophospholipid translocase (flippase). ATP-
ase II was originally thought to be responsible for flipping
phosphatidylserine from the external leaflet of the lipid bi-
layer to prevent recognition of the cell by the apoptotic
apparatus. Drs2p seemed to fit this bill for yeast, as the
mutant apparently failed to flip a lipid derivative across
 
the plasma membrane, and an earlier study localized Drs2p
by fractionation to the plasma membrane.
But in a more recent study, the 
 
drs2
 
 mutant did not
show differences in lipid transport across the plasma mem-
brane. The new localization results of Chen et al. suggest
that any possible Drs2p flippase activity would be found in
the TGN, not at the plasma membrane.
The ATPase activity of Drs2p is necessary for its traf-
ficking function, but Todd Graham says he must now con-
firm that the enzyme is a flippase, and see if Drs2p activity
has any effect in vitro on the tubulation or ARF recruit-
ment of purified Golgi membranes.
 
Balancing Forces in Meiosis
 
On page 1137, Matthies et al. demonstrate that balanced
forces in the metaphase spindle allow the correct segrega-
tion of chromosomes that lack recombinational linkages.
 
The linkages, or chiasmata, are the products of recombi-
nation that normally hold chromosome pairs together in
the first meiotic division. A fly’s fourth chromosomes are
small and packed with poorly recombining heterochroma-
tin, so they must do without chiasmata. They resort instead
to a weak heterochromatin-based affinity that usually
breaks apart soon after spindle formation, and well before
the extended metaphase arrest is released in the oocyte. Up
to 10% of fly X chromosomes also fail to recombine and
follow a similar pathway of achiasmate segregation, and
many errors in human chromosome segregation involve
chromosomes that show no signs of prior recombination.
The first of the balanced forces is directed polewards. It
may be generated by microtubule flux or a motor at the ki-
netochore; in these experiments it is eliminated by a muta-
 
tion in the 
 
tub67C
 
 gene, which encodes a divergent 
 
a
 
 tubu-
lin. Chromatin in the mutant is no longer stretched along
the spindle during metaphase arrest, and centromeres are
not distributed to the polewards ends of the chromatin
mass. The result is an increase in achiasmate non-disjunc-
tion.
These phenotypes are reversed by reducing the dosage
of the Nod kinesin, the source of the opposing force. Nod
attaches to DNA, and has been postulated to provide a
force pushing chromosomes back into the spindle. Some
Nod is needed to keep chromosomes from flying out of the
spindle, but too much Nod pushes the achiasmate chromo-
somes together even after the heterochromatin linkage
 
has dissolved, thus confounding any heterochromatin-
directed segregations.
 
Linking Actin and Microtubules
 
A protein dubbed microtubule actin cross-linking factor
(MACF) is described by Leung et al. on page 1275. As its
name suggests, MACF is capable of binding both actin fil-
aments and microtubules in vitro, and it colocalizes with
both cytoskeletal systems in vivo. Expression of the pro-
tein, especially a truncated version, results in the close ap-
position of actin filaments and microtubules.
 
MACF is a hybrid protein: it has an actin-binding
amino terminus resembling some of the plakins (which
link actin and intermediate filaments), whereas its central
stem and part of the carboxy-terminal tail resemble pro-
teins from the spectrin superfamily. The third, novel, com-
ponent is a unique microtubule-binding domain at the car-
boxyl terminus.
MACF is a homologue of the 
 
Drosophila
 
 protein
Kakapo, which was described in three papers in the No-
 
vember 30, 1998 issue of this journal. An actin filament–
microtubule linking function would explain the varied
structural and neuronal defects in 
 
kakapo
 
 mutants. In
other cells, an actin filament–microtubule linker could im-
part rigidity, anchor and position the spindle, and transfer
neuronal vesicles from microtubules to actin.
 
PKA Anchors and Lets Go
 
An Anchoring Complex for Chromatin Condensation
 
The large condensin complex that condenses chromatin in
mitosis has a natural affinity for DNA, but it binds to chro-
matin only during mitosis, and it is not clear if it can do so
by itself. Collas et al. (page 1167) indicate that AKAP95,
an anchoring protein for the cyclic AMP (cAMP)-acti-
vated protein kinase A (PKA), may be one factor that
tethers condensins to chromatin.
Collas et al. find that PKA activity is needed for mainte-
nance of chromatin condensation. As AKAP95 anchors
 
In Brief 
The Journal of Cell Biology, Volume 147, 1999 2
 
the regulatory subunits of PKA, the catalytic subunits may
phosphorylate chromatin substrates in a burst as the cata-
lytic subunits are released, before they cycle back onto the
chromatin, possibly in a preformed complex with the regu-
latory subunits and AKAP95.
AKAP95, but not PKA, is needed for the establishment
of chromatin condensation. AKAP95 antibodies prevent
the recruitment of the condensin component Eg7 to
chromatin, and AKAP95 and Eg7 coprecipitate. This sug-
gests that, like other AKAPs, AKAP95 may anchor more
than PKA.
 
Letting Go of MAP Kinase
 
The cyclic AMP (cAMP)-activated PKA is known to influ-
ence the MAP kinase pathway, for example at the level of
Ras action. Blanco-Aparicio et al. (page 1129) and Saxena
et al. (Saxena, M., S. Williams, K. Taskén and T. Mustelin.
 
1999. 
 
Nat. Cell Biol.
 
 1:305–311) now show that PKA can
also activate MAP kinases by disabling their association
with protein tyrosine phosphatases that contain a MAP ki-
nase interaction motif (KIM).
Blanco-Aparicio et al. find that, both in vitro and in
vivo, PKA phosphorylates a serine within the KIM of the
brain-specific phosphatase PTP-SL. This causes PTP-SL to
release the MAP kinases from its grasp, thus allowing the
MAP kinases to activate and enter the nucleus. Saxena et
al. define a similar mechanism used by the hematopoietic
tyrosine phosphatase HePTP, and demonstrate that it is
sufficient to induce downstream events such as c-
 
fos
 
 tran-
scription.
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